[ Price : $8.95]
FDA approves Gileads Yeztugo as the only HIV pre-exposure prophylaxis twice-yearly option.[ Price : $8.95]
FDA publishes a guidance on its implementation of the post-Warning Letter meeting established in the GDUFA 3 commitment letter to ...[ Price : $8.95]
House Energy and Commerce Committee ranking Democrat Frank Pallone calls for a bipartisan committee investigation of HHS secretary...[ Price : $8.95]
CBER director Vinay Prasad has been appointed as FDAs chief medical and scientific officer, a new combination role for commissione...[ Price : $8.95]
Bavarian Nordic enters into an agreement to sell for $160 million a priority review voucher that was awarded for gaining approval ...[ Price : $8.95]
A Texas federal judge rules FDA acted properly in removing Novo Nordisks Ozempic and Wegovy from its drug shortage list.[ Price : $8.95]
Former FDA commissioner Scott Gottlieb expects FDA will reevaluate Sareptas approval of Duchenne muscular dystrophy gene therapy E...[ Price : $8.95]
FDA Webview closes and will not be publishing on 6/19 in recognition of the U.S. federal holiday, Juneteenth.